CXCR5 and myeloid sarcoma: This hypothesis was reinforced when we examined the expression of cell surface CXCR5 receptor in different circulating T and B cells subpopulations and observed an increased percentage of regulatory T cells positive for CXCR5 in MS patients carrying the minor allele for rs10892307 (G) with respect to non-carriers.